Ismael Herruzo
Papers
1
Total Citations
4
H-Index
1
About
Ismael Herruzo is a leading researcher in urologic oncology, with a primary focus on improving treatment outcomes for localized prostate cancer through patient-centered methodologies. His most impactful work centers on comparative effectiveness research, leveraging Patient-Reported Outcome Measures (PROMs) to evaluate the real-world impact of modern treatment modalities. Herruzo’s landmark 2023 study, with 4 citations, systematically compared active surveillance, robot-assisted radical prostatectomy (RARP), and intensity-modulated radiotherapy, providing critical evidence on how these interventions affect patients’ quality of life and functional outcomes. This contribution is notable for shifting the conversation from purely clinical metrics to the patient’s lived experience, offering a more holistic framework for treatment decision-making. By integrating PROMs into comparative effectiveness research, Herruzo has helped bridge the gap between clinical efficacy and patient-reported well-being, influencing both urological practice and health policy. His work is essential reading for clinicians and researchers seeking to understand the trade-offs between cancer control and quality of life in prostate cancer care.
Research Focus
Key Achievements
Top Papers
- 1